Company Information
Industry 卫生和社会工作业
Company Introduction 创新医疗管理股份有限公司是一家集珍珠养殖、加工、设计、销售、进出口、科学研究、医药保健开发于一体的、经国家八部委认定的目前珍珠行业唯一一家农业产业化国家重点龙头企业,是目前珍珠行业规模最大企业,拥有的现代化厂房,装备了国内外先进的生产设备,形成了从珍珠养殖、优化处理、项链首饰加工、精深加工等多条生产线,通过了ISO9001质量体系认证、ISO14000环境体系认证,公司的"千足"商标被认定为"中国驰名商标"。2016年02月05日公司完成重大资产重组千足珍珠将从淡水珍珠饰品的加工生产和批发零售业进入医疗服务行业,实现多元化经营战略,由单一的淡水珍珠饰品供应商转变为珍珠饰品生产销售与医疗服务并行的双主业。
Main Business 提供高品质医疗服务为主营业务
Legal Representative 陈海军
Top Executives
董事长:陈海军
董事:游向东,华晔宇,何飞勇,何永吉,阮光寅,陈海军
独立董事:陈文强,黄韬,姚航平
Top 5 Shareholder
Shareholder name Nature Holding Date
陈夏英流通A股17.59%30/09/2024
上海洸焕科技有限公司流通A股7.64%30/09/2024
陈海军限售股+流通A股5.04%30/09/2024
杭州昌健投资合伙企业(有限合伙)流通A股5.00%30/09/2024
上海一村投资管理有限公司-一村金牛六号私募投资基金流通A股1.65%30/09/2024
Company Secretary 郭立丹
Solicitors 上海市锦天城律师事务所
Auditors 立信会计师事务所(特殊普通合伙)
Tel No 0575-87160891
Fax No 0575-87160531
Website www.chxyl.com
Email cxyl002173@126.com
Company Address
Register: 浙江省诸暨市山下湖镇郑家湖村
Office: 浙江省诸暨市山下湖珍珠工业园区
Listing Date 25/09/2007
Shares Capital
Shares Capital: 441,284,352
Total A Share: 441,284,352
Listed A Share: 415,686,468
Non-tradable A Share: 25,597,884
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.080
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 4.165
Market Capitalization(RMB) 4.581B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.